Provided by Tiger Trade Technology Pte. Ltd.

Lantheus

99.97
-0.2700-0.27%
Post-market: 99.970.00000.00%19:30 EDT
Volume:1.08M
Turnover:107.72M
Market Cap:6.51B
PE:24.02
High:100.46
Open:100.44
Low:99.97
Close:100.24
52wk High:111.86
52wk Low:49.67
Shares:65.10M
Float Shares:58.53M
Volume Ratio:0.62
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.16
EPS(LYR):3.41
ROE:22.21%
ROA:8.38%
PB:4.96
PE(LYR):29.32

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX)

TIPRANKS
·
Mar 18

BRIEF-Lantheus Announces Three-Month Extension Of PDUFA Date For LNTH-2501

Reuters
·
Mar 18

Lantheus announces three-month extension of LNTH-2501 PDUFA date

TIPRANKS
·
Mar 18

US FDA extends review of Lantheus' diagnostic imaging kit by three months

Reuters
·
Mar 18

Lantheus Holdings Inc - FDA Extends Review of Lnth-2501 Nda to June 29, 2026

THOMSON REUTERS
·
Mar 18

Lantheus Announces Three-Month Extension of Pdufa Date for Lnth-2501 (Ga 68 Edotreotide), a Pet Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (Sstr+) Neuroendocrine Tumors (Nets)

THOMSON REUTERS
·
Mar 18

Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

GlobeNewswire
·
Mar 18

Lantheus price target raised to $110 from $105 at Jefferies

TIPRANKS
·
Mar 18

Lantheus Holdings Up Over 9%, on Pace for Largest Percent Increase Since February 2025 -- Data Talk

Dow Jones
·
Mar 10

Analysts’ Top Healthcare Picks: IDEAYA Biosciences (IDYA), Lantheus (LNTH)

TIPRANKS
·
Mar 09

Analysts Are Bullish on Top Healthcare Stocks: Dianthus Therapeutics (DNTH), Lantheus (LNTH)

TIPRANKS
·
Mar 09

Korn Ferry, Hewlett Packard Enterprise And 3 Stocks To Watch Heading Into Monday

Benzinga Earnings
·
Mar 09

US FDA approves Lantheus’ new prostate cancer imaging formulation

Reuters
·
Mar 07

Lantheus Holdings Inc - Pylarify Truvu Expected to Launch in Q4 2026 With Phased Rollout

THOMSON REUTERS
·
Mar 07

Lantheus Announces FDA Approval of Pylarify Truvu™ (Piflufolastat F 18) Injection

THOMSON REUTERS
·
Mar 07

Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection

GlobeNewswire
·
Mar 07

Stock Track | Lantheus Soars 5.07% Intraday on FDA Tentative Approval and Analyst Price Target Hike

Stock Track
·
Mar 02

Lantheus Says US FDA Tentatively Approves PNT2003

MT Newswires Live
·
Mar 02

Lantheus Holdings Is Maintained at Buy by Truist Securities

Dow Jones
·
Mar 02

Lantheus receives U.S. FDA tentative approval for Lutetium Lu 177

TIPRANKS
·
Mar 02